Literature DB >> 7807603

Effects of amrinone on cardiac contraction and relaxation in isolated, perfused rat heart.

Y X Ma1, H Y Zhao.   

Abstract

The effects of amrinone on cardiac contraction and relaxation were assessed in isolated, perfused rat hearts. It was found that the left ventricular developed pressure (LVDP), dp/dtmax and -da/dtmax did not significantly increase, and the time constant (tau) did not markedly shorten with perfusion of low concentration (1 nmol/L, 100 nmol/L) of amrinone. The perfusion with higher concentration (1000 nmol/L) of amrinone reduced LVDP (P < 0.01), dp/dtmax (P < 0.01), -dp/dtmax (P < 0.01), and prolonged tau (P < 0.05) significantly. It was assumed that amrinone has no direct positive inotropic effect, and can not improve cardiac relaxation. On the contrary, the cardiac contraction and relaxation will be inhibited at higher concentration of amrinone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7807603     DOI: 10.1007/bf02886799

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  7 in total

1.  Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol.

Authors:  B G Firth; A V Ratner; E D Grassman; M D Winniford; P Nicod; L D Hillis
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778

2.  Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function.

Authors:  P T Wilmshurst; D S Thompson; B S Jenkins; D J Coltart; M M Webb-Peploe
Journal:  Br Heart J       Date:  1983-01

3.  Differential effects of amrinone on contractility and taurine influx in rat and guinea pig hearts.

Authors:  J Azari; R J Huxtable
Journal:  Eur J Pharmacol       Date:  1980-10-31       Impact factor: 4.432

4.  Cardiac effects of amrinone on rabbit papillary muscle and guinea pig Langendorff heart preparations.

Authors:  G Onuaguluchi; R D Tanz
Journal:  J Cardiovasc Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.105

5.  Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.

Authors:  P T Wilmshurst; D S Thompson; S M Juul; B S Jenkins; D J Coltart; M M Webb-Peploe
Journal:  Br Heart J       Date:  1984-07

6.  Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.

Authors:  P T Wilmshurst; D S Thompson; S M Juul; H C Dittrich; J R Dawson; J M Walker; B S Jenkins; D J Coltart; M M Webb-Peploe
Journal:  Br Heart J       Date:  1985-05

7.  Dobutamine potentiates amrinone's beneficial effects in moderate but not in advanced heart failure. 31P-MRS in isolated hamster hearts.

Authors:  P T Buser; W Auffermann; S T Wu; G Jasmin; W W Parmley; J Wikman-Coffelt
Journal:  Circ Res       Date:  1990-03       Impact factor: 17.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.